store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Latrepirdine dihydrochloride (Dimebolin dihydrochloride) 是一种具有口服活性和神经活性的多种药物靶点的拮抗剂,可刺激淀粉样前体蛋白分解代谢和 β-淀粉样蛋白分泌。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 374 | 现货 | ||
5 mg | ¥ 622 | 现货 | ||
10 mg | ¥ 788 | 现货 | ||
25 mg | ¥ 1,730 | 现货 | ||
50 mg | ¥ 2,970 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 683 | 现货 |
产品描述 | Latrepirdine dihydrochloride (Dimebolin dihydrochloride) is an orally active, and neuroactive antagonist of multiple drug targets, including histamine receptors, GluR, and 5-HT receptors, used as an antihistamine drug. |
体外活性 | Latrepirdine increases succinate dehydrogenase activity (MTT-assay), mitochondrial membrane potential (DeltaPsim), and cellular ATP levels in primary mouse cortical neurons and human neuroblastoma cells (SH-SY5Y). Latrepirdine enhances mitochondrial function both in the absence and presence of stress and Dimebon-treated cells are partially protected to maintain cell viability. [1] Latrepirdine leads to enhanced mTOR- and Atg5-dependent autophagy in cultured mammalian cells. [2] latrepirdine stimulates MTOR- and ATG5-dependent autophagy, leading to the reduction of intracellular levels of APP metabolites, including Aβ in cultured cells. [3] Latrepirdine stimulates the degradation of α-syn in differentiated SH-SY5Y neurons, and in mouse brain following chronic administration, in parallel with elevation of the levels of markers of autophagic activity. [4] Latrepirdine increases intracellular ATP levels and glucose transporter 3 translocation to the plasma membrane in primary neuron. [5] |
体内活性 | Latrepirdine treatment of TgCRND8 transgenic mice is associated with improved learning behavior and with a reduction in accumulation of Aβ42 and α-synuclein. [2] Latrepirdine administration results in increased levels of the biomarkers thought to correlate with autophagy activation in the brains of TgCRND8 (APP K670M, N671L, V717F) or wild-type mice, and that treatment is associated with abrogation of behavioral deficit, reduction in Aβ neuropathology, and prevention of autophagic failure among TgCRND8 mice. [3] |
别名 | Dimebolin dihydrochloride, Latrepirdine, Latrepirdine 2HCl, Dimebolin |
分子量 | 392.37 |
分子式 | C21H25N3·2HCl |
CAS No. | 97657-92-6 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 39.2 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5486 mL | 12.7431 mL | 25.4861 mL | 63.7154 mL |
5 mM | 0.5097 mL | 2.5486 mL | 5.0972 mL | 12.7431 mL | |
10 mM | 0.2549 mL | 1.2743 mL | 2.5486 mL | 6.3715 mL | |
20 mM | 0.1274 mL | 0.6372 mL | 1.2743 mL | 3.1858 mL | |
50 mM | 0.051 mL | 0.2549 mL | 0.5097 mL | 1.2743 mL | |
100 mM | 0.0255 mL | 0.1274 mL | 0.2549 mL | 0.6372 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Latrepirdine dihydrochloride 97657-92-6 Autophagy GPCR/G Protein Immunology/Inflammation Neuroscience Beta Amyloid 5-HT Receptor Adrenergic Receptor GluR Histamine Receptor Serotonin Receptor 5-hydroxytryptamine Receptor Dimebolin dihydrochloride Amyloid-β Inhibitor Dimebolin Dihydrochloride Latrepirdine inhibit Latrepirdine 2HCl Abeta Dimebolin Latrepirdine Dihydrochloride β-amyloid peptide Beta Receptor inhibitor